Paradromics is a neurotechnology company building data-driven brain-computer interface (BCI) technologies focused on brain health. Its high-speed BCI platform records neural activity at single-neuron resolution and uses advanced decoding to translate brain signals into actionable health data, enabling new therapeutics and communication possibilities for patients with paralysis, movement disorders, chronic pain, addiction, depression, and other conditions. The Connexus BCI aims to restore speech and communication for individuals unable to speak due to ALS, spinal cord injury, or stroke, with ongoing clinical studies and FDA-approved pathways. Based on scalable hardware and AI-driven software models, the company develops adaptable solutions to process expansive brain-activity datasets across multiple implants to broaden healthcare applications.”
No recent news for this company.
No recent deals for this company.